Antitumor cytostatic doxorubicin in liposomal form does not have a damaging effect on mitochondria
- Авторлар: Nikitina E.R1, Korotkov S.M1, Petunov S.G1, Vasileva K.A1, Mindukshev I.V1, Krivchenko A.I1
-
Мекемелер:
- Sechenov Institute of evolutionary physiology and biochemistry RAS
- Шығарылым: Том 14, № 3 (2019)
- Беттер: 85-86
- Бөлім: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.09.2019
- URL: https://genescells.ru/2313-1829/article/view/122419
- DOI: https://doi.org/10.23868/gc122419
- ID: 122419
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Толық мәтін
Авторлар туралы
E. Nikitina
Sechenov Institute of evolutionary physiology and biochemistry RAS
Email: elena.nikitina@bk.ru
St. Petersburg, Russia
S. Korotkov
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
S. Petunov
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
K. Vasileva
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
I. Mindukshev
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
A. Krivchenko
Sechenov Institute of evolutionary physiology and biochemistry RASSt. Petersburg, Russia
Әдебиет тізімі
- Forrancs V.J. Overview of cardiac pathology in relation to anthracydine cardiac toxicity. Canc. Treat. Rep. 1978; 62: 955-61.
- Olson R.D., Mushlin P.S., Brenner D.E. et al. Doxorubicin cardio-toxicity may be caused by its metabolite, doxorubicinol. PNAS USA 1988; 85(10): 3585-9.
- Harrington K.L., Lewanski C.R., Stewart S.W. Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development. Clin. Oncol. 2000; 12: 16-24.
Қосымша файлдар
